NCCM
ARNA

Nine Chapters Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Nine Chapters Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-18,020
Closed -$263K – 210
2017
Q1 		$263K Buy
+18,020
New +$267K 0.35% 126

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Nine Chapters Capital Management's ARNA Position: Q2 2017 in Review

Nine Chapters Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2017, closing a stake of 18,020 shares — an estimated $263K sold.

Nine Chapters Capital Management first reported a position in ARNA in Q1 2017 and held it in 1 quarter. The position peaked at $263K in Q1 2017. 102 funds tracked by Wall St. Rank hold ARNA as of Q2 2017.

  • Nine Chapters Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q2 2017 after selling out during the quarter.
  • Nine Chapters Capital Management sold 18,020 Arena Pharmaceuticals Inc shares in Q2 2017, an estimated $263K.
  • Nine Chapters Capital Management first reported a position in Arena Pharmaceuticals Inc in Q1 2017 and held it in 1 quarter.
  • Nine Chapters Capital Management's Arena Pharmaceuticals Inc position peaked at $263K in Q1 2017.
  • 102 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2017.

Based on Nine Chapters Capital Management's 13F filing for Q2 2017, filed 31 Jul 2017.